A categorical typology of naltrexone-adopting private substance abuse treatment centers

Journal of Substance Abuse Treatment

Volumn 34, Issue 4, 2008, Pages 433-442

  Oser, Carrie B ^a   Roman, Paul M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Center for Research on Behavioral Health   (United States)

Author keywords

Categorical typology; Innovation adoption; Naltrexone; Organizations

Indexed keywords

NALTREXONE;

ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OPIATE ADDICTION; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL STATUS;

HUMANS; NALTREXONE; PRIVATE SECTOR; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 42949101263     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2007.08.003     Document Type: Article

References (59)

1. Abrahamson R. Managerial fads and fashions: The diffusion and rejection of innovations. Academy of Management Review 16 (1991) 586-612
2. Abrahamson R., and Rosenkopf L. Institutional and competitive bandwagons: Using mathematical modeling as a tool to explore innovation diffusion. Academy of Management Review 18 (1993) 487-517
3. Anton R.F., Moak D.H., Waid R., Latham P.K., Malcolm R.J., and Dias J.K. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. American Journal of Psychiatry 156 (1999) 1758-1764
4. In: Backer T.E., David S.L., and Soucy G. (Eds). Reviewing the behavioral science knowledge base on technology transfer: NIDA Research Monograph No. 155 (1995), National Institute on Drug Abuse (NIDA), Rockville, MD 1-20
5. Berwick D.M. Disseminating innovations in health care. Journal of the American Medical Association 289 (2003) 1969-1975
6. Brahen H.S., Henderson R.K., Capone T., and Kondal N. Naltrexone treatment in a jail work release program. Journal of Clinical Psychiatry 45 (1984) 49-52
7. Castle N.G. Innovation in nursing homes: Which facilities are the early adopters?. Gerontologist 41 (2001) 161-172
8. Chick J.R., Anton R., Checinski K., Croop R.S., Drummond D.C., Farmer R., et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence and abuse. Alcohol & Alcoholism 35 (2000) 587-593
9. Damanpour F. The adoption of technological, administrative, and ancillary innovations: Impact of organizational factors. Journal of Management 13 (1987) 675-688
10. Damanpour F. Organizational innovation: A meta-analysis of effects of determinants and moderators. Academy of Management Journal 34 (1991) 555-590
11. Dewar R.D., and Dutton J.E. The adoption of radical and incremental innovations: An empirical analysis. Management Science 32 (1986) 1422-1433
12. Dickerson M.D., and Gentry J.W. Characteristics of adopters and non-adopters of the home computer. Journal of Consumer Research 10 (1983) 225-235
13. DiMaggio P.J., and Powell W.W. The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. American Sociological Review 48 (1983) 147-160
14. Ducharme L.J., Knudsen H.K., and Roman P.M. Evidence-based treatment for opiate-dependent clients: Availability, variation, and organizational correlates. American Journal of Drug and Alcohol Abuse 32 (2007) 569-576
15. Ducharme L.J., Knudsen H.K., Roman P.M., and Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 32 (2006) 321-329
16. Ely J.W., Osheroff J.A., Ebell M.H., Chambliss M.E., Vinson D.C., Stevermer J.L., et al. Obstacles to answering doctors' questions about patient care with evidence: Qualitative study. British Medical Journal 324 (2002) 710-713
17. Fahey L., and Narayanan V.K. Linking changes in revealed causal maps and environmental change: An empirical study. Journal of Management Studies 26 (1989) 361-378
18. Gatignon H., and Robertson T.S. Technology diffusion: An empirical test of competitive effects. Journal of Marketing 53 (1989) 35-49
19. Goes J.B., and Ho Park S. Interorganizational links and innovation: The case of hospital services. Academy of Management Journal 40 (1997) 673-696
20. Greco A.J., and Fields D.M. Profiling early triers of service innovations: A look at interactive home video ordering services. Journal of Services Marketing 5 (1991) 19-26
21. Griffith J.R., Sahney V.K., and Mohr R.A. Reengineering health care: Building on CQU (1995), Health Administration Press, Ann Arbor, MI
22. Ibarra H. Network centrality, power, and innovation involvement: Determinants of technical and administrative roles. Academy of Management Journal 36 (1993) 471-501
23. Jones M.I., Greenfield S.M., and Bradley C.P. Prescribing new drugs: Qualitative study of influences on consultants and general practitioners. British Medical Journal 323 (2001) 378-381
24. Kimberly J.R., and Evanisko M.J. Organizational innovation: The influence of individual, organizational, and contextual factors on hospital adoption of technological and administrative innovations. Academy of Management Journal 24 (1981) 689-713
25. Kirchmayer U., Davoli M., Verster A.D., Amato L., Ferri M., and Perucci C.A. A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 97 (1997) 1241-1249
26. Knudsen H.K., Ducharme L.J., and Roman P.M. Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors. Journal of Substance Abuse Treatment 30 (2006) 363-373
27. Knudsen H.K., Ducharme L.J., and Roman P.M. The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence 87 (2007) 164-174
28. Knudsen H.K., and Roman P.M. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment 26 (2004) 353-361
29. Knudsen H.K., Roman P.M., Ducharme L.J., and Johnson J.A. Organizational predictors of pharmacological innovation adoption: The case of disulfiram. Journal of Drug Issues 35 (2005) 559-574
30. Krystal J.H., Cramer J.A., Krol W.F., Kirk G.F., and Rosenheck R.A. Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine 345 (2001) 1734-1739
31. In: Lamb S., Greenlick M.R., and McCarty D. (Eds). Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment (1998), National Academy Press, Washington, DC
32. Lehman W.E.K., Greener J.M., and Simpson D.D. Assessing organizational readiness for change. Journal of Substance Abuse Treatment 22 (2002) 197-209
33. Ling W., and Wesson D.R. Naltrexone treatment for addicted health care professionals: A collaborative private practice experience. Journal of Clinical Psychiatry 45 (1984) 46-48
34. Long J.S., and Freese J. Regression models for categorical dependent variables using Stata (2001), Stata Press Publication, College Station, TX
35. Magura S., Schildhaus S., Rosenblum A., and Gastfriend D. Substance user treatment program quality: Selected topics. Substance Use and Misuse 37 (2002) 1185-1214
36. Martinez E., Polo Y., and Flavian C. The acceptance and diffusion of new consumer durables: Differences between first and last adopters. Journal of Consumer Marketing 15 (1998) 323-334
37. McLellan A.T., Lewis D.C., O'Brien C.P., and Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 284 (2000) 1695-1698
38. Meyer M., Johnson J.D., and Ethington C. Contrasting attributes of preventive health innovations. Journal of Communication 47 (1997) 112-131
39. Mohr R. An institutional perspective on rational myths and organizational change in health care. Medical Care Reviews 49 (1992) 233-255
40. Nohria N., and Eccles R.G. Networks and organizations (1992), Harvard Business School Press, Boston
41. O'Brien C.P., Volpicelli L.A., and Volpicelli J.R. Naltrexone in the treatment of alcoholism: A clinical review. Alcohol: An International Biomedical Journal 13 (1996) 35-39
42. O'Malley S.S., Jaffe A., Chang G., Schottenfeld R.S., Meyer R.E., and Rounsaville B.J. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 49 (1992) 881-887
43. O'Neill H.M., Pouder R.W., and Buchholtz A.K. Patterns in the diffusion of strategies across organizations: Insights from the innovation diffusion literature. Academy of Management Review 23 (1998) 98-114
44. Oliver C. Determinants of interorganizational relationships: Integration and future directions. Academy of Management Review 15 (1990) 241-265
45. Oser C., Staton-Tindall M., and Leukefeld C. HIV/AIDS testing in correctional agencies and community treatment programs: The impact of internal organizational structure. Journal of Substance Abuse Treatment 32 (2007) 301-310
46. Oser, C. B., Roman, P. M. (in press). Organizational-level predictors of adoption across time: Naltrexone in private addiction treatment centers. Journal of Studies on Alcohol and Drugs.
47. Oslin D.W., Pettinati H.M., Volpicelli J.R., Wolf A.L., Kampman K.M., and O'Brien C.P. The effects of naltrexone on alcohol and cocaine use in dually addicted patients. Journal of Substance Abuse Treatment 16 (1999) 163-167
48. Rai A., Ravichandran T., and Samaddar S. How to anticipate the Internet's global diffusion. Communications of the ACM 41 (1998) 97-106
49. Rogers E.M. Categorizing the adopters of agricultural practices. Rural Sociology 23 (1958) 346-354
50. Rogers E.M. Diffusion of innovations. 5th ed. (2003), The Free Press, New York
51. Roman P.M., and Johnson J.A. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment 22 (2002) 1-8
52. Stine S.M., and Kosten T.R. New treatments for opiate dependence (1997), The Guilford Press, New York
53. Thomas J.B., and Trevino L.K. Information processing in strategic alliance building: A multiple-case approach. Journal of Management Studies 30 (1993) 779-814
54. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49 (1992) 876-880
55. Volpicelli J.R., Rhines K.C., Rhines J.S., Volpicelli L.A., Alterman A.I., and O'Brien C.P. Naltrexone and alcohol dependence. Archives of General Psychiatry 54 (1997) 737-742
56. Washton A.M., Pottash A.C., and Gold M.A. Naltrexone in addicted business executives and physicians. Journal of Clinical Psychiatry 45 (1984) 39-41
57. Westphal J.D., Gulati R., and Shortell S.M. Customization or conformity? An institutional and network perspective on the content and consequences of TQM adoption. Administrative Science Quarterly 42 (1997) 366-394
58. Wolfe R., and Gould W. An approximate likelihood-ratio test for ordinal response models. Stata Technical Bulletin 42 (1998) 24-27
59. Yan Tam K. Dynamic price elasticity and the diffusion of mainframe computing. Journal of Management Information System 13 (1996) 163-183